TXR-1210

N/A

Report date: 2025/05/27 11:03:01
NME

Base Information

Drug NameTXR-1210
Drug Alias NameTXR-1210TXR 1210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 modulatorsTransforming growth factor beta inhibitors
TargetsInterleukin-1Transforming growth factor beta
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAria Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A